Open Access
Issue |
Med Sci (Paris)
Volume 39, Number 8-9, Août–Septembre 2023
|
|
---|---|---|
Page(s) | 591 - 593 | |
Section | Nouvelles | |
DOI | https://doi.org/10.1051/medsci/2023087 | |
Published online | 11 September 2023 |
- Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis 2021; 17 : 365–70. [CrossRef] [Google Scholar]
- Ramachandran P, Pellicoro A, Vernon MA, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA 2012 ; 109 : E3186–E3195. [Google Scholar]
- Ramachandran P, Dobie R, Wilson-Kanamori JR, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 2019 ; 575 : 512–518. [CrossRef] [PubMed] [Google Scholar]
- Lett MJ, Mehta H, Keogh A, et al. Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells. Gut 2022; 71 : 2526–38. [CrossRef] [PubMed] [Google Scholar]
- Klenerman P, Hinks T SC, Ussher JE. Biological functions of MAIT cells in tissues. Mol Immunol 2021; 130 : 154–8. [CrossRef] [PubMed] [Google Scholar]
- Nel I, Bertrand L, Toubal A, et al. MAIT cells, guardians of skin and mucosa? Mucosal Immunol 2021; 14 : 803–14. [CrossRef] [PubMed] [Google Scholar]
- Du Halgouet A, Darbois A, Alkobtawi M, et al. Role of MR1-driven signals and amphiregulin on the recruitment and repair function of MAIT cells during skin wound healing. Immunity 2023; 56 : 78–92.e6. [CrossRef] [PubMed] [Google Scholar]
- Toubal A, Nel I, Lotersztajn S, et al. Mucosal-associated invariant T cells and disease. Nat Rev Immunol 2019 ; 19 : 643–657. [CrossRef] [PubMed] [Google Scholar]
- Hegde P, Weiss E, Paradis V, et al. Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. Nat Commun 2018 ; 9 : 2146. [CrossRef] [PubMed] [Google Scholar]
- Guillot A, Hamdaoui N, Bizy A, et al. Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver. Hepatology 2014 ; 59 : 296–306. [CrossRef] [PubMed] [Google Scholar]
- Böttcher K, Rombouts K, Saffioti F, et al. MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation. Hepatology 2018 ; 68 : 172–186. [CrossRef] [PubMed] [Google Scholar]
- Mabire M, Hegde P, Hammoutene A, et al. MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming. Nat Commun 2023; 14 : 1830. [CrossRef] [PubMed] [Google Scholar]
- Gilgenkrantz H. Un dialogue indispensable entre cellules MAIT et microbiote. Med Sci (Paris) 2020; 36 : 313–6. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Magalhaes I, Lehuen A. Les lymphocytes MAIT dans le diabète de type 2 et l’obésité. Med Sci (Paris) 2015 ; 31 : 717–719. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Rouxel O, Lehuen A. Les cellules MAIT : un lien entre l’intestin et le diabète de type 1. Med Sci (Paris) 2018 ; 34 : 518–522. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.